CD274 and neoplasm: Nevertheless, because of intra-tumour heterogeneity and clonal evolution that make tissue sampling a suboptimal portrayal of the tumour molecular profile, PD-L1 expression on CTCs could be by far more convenient for both clinicians and patients, allowing a longitudinal assessment of PD-L1 expression during the different clinical phases of the disease [23].